FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Water-Jel Technologies Lidocaine Wound Gel Recall

Lidocaine Wound Gel (Benzalkonium Chloride, 0

Water-Jel Technologies, LLC · Huntersville, NC

Risk level
Class III
Reported by FDA
May 6, 2026
Recall ID
D-0509-2026
Check your lot numberHow we source this data

Summary

Water-Jel Technologies recalled Lidocaine Wound Gel starting Apr 7, 2026. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0509-2026 on May 6, 2026. Reason: Failed PH Specifications. Status: Ongoing.

Why it was recalled

Failed PH Specifications

Product description

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950

Lot numbers, UPCs & expiration codes

Lots: A5014, A5018, A5019

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0509-2026
Classification
Class III
Status
Ongoing
Recall initiated
Apr 7, 2026
FDA report date
May 6, 2026
Quantity
31,488 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Water-Jel Technologies, LLC

Original FDA data

Every field from FDA enforcement report D-0509-2026, exactly as published.

Show all FDA fields
City
Huntersville
State
NC
Status
Ongoing
Country
United States
Event ID
98737
Address
13359 Reese Blvd East
Code information
Lots: A5014, A5018, A5019
Postal code
28078
Report date
May 6, 2026
Product type
Drugs
Recall number
D-0509-2026
Classification
Class III
Recalling firm
Water-Jel Technologies, LLC
Product quantity
31,488 tubes
Reason for recall
Failed PH Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 7, 2026
Initial firm notification
Letter
Center classification date
Apr 30, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0509-2026, published May 6, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls